Related references
Note: Only part of the references are listed.Perifoveal Chorioretinal Atrophy after Subretinal Voretigene Neparvovec-rzyl for RPE65-Mediated Leber Congenital Amaurosis
William S. Gange et al.
OPHTHALMOLOGY RETINA (2022)
Restoration of visual function in adult mice with an inherited retinal disease via adenine base editing
Susie Suh et al.
NATURE BIOMEDICAL ENGINEERING (2021)
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia
H. Frangoul et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
In vivo PCSK9 gene editing using an all-in-one self-cleavage AAV-CRISPR system
Qian Li et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2021)
CRISPR/Cas-Dependent and Nuclease-Free In Vivo Therapeutic Gene Editing
Ishani Dasgupta et al.
HUMAN GENE THERAPY (2021)
Adenine base editing in an adult mouse model of tyrosinaemia
Chun-Qing Song et al.
NATURE BIOMEDICAL ENGINEERING (2020)
Correlation between mouse age and human age in anti-tumor research: Significance and method establishment
Shuo Wang et al.
LIFE SCIENCES (2020)
Efficient Generation and Correction of Mutations in Human iPS Cells Utilizing mRNAs of CRISPR Base Editors and Prime Editors
Duran Sueruen et al.
GENES (2020)
Long-Term Follow-Up of the First in Human Intravascular Delivery of AAV for Gene Transfer: AAV2-hFIX16 for Severe Hemophilia B
Lindsey A. George et al.
MOLECULAR THERAPY (2020)
Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors
Andrew V. Anzalone et al.
NATURE BIOTECHNOLOGY (2020)
First Trial of CRISPR-Edited T cells in Lung Cancer
Simon F. Lacey et al.
TRENDS IN MOLECULAR MEDICINE (2020)
CRISPR-Cas9 DNA Base-Editing and Prime-Editing
Ariel Kantor et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Therapy in Rhodopsin-Mediated Autosomal Dominant Retinitis Pigmentosa
Da Meng et al.
MOLECULAR THERAPY (2020)
Prime editing for functional repair in patient-derived disease models
Imre F. Schene et al.
NATURE COMMUNICATIONS (2020)
Unlocking HDR-mediated nucleotide editing by identifying high-efficiency target sites using machine learning
Aidan R. O'Brien et al.
SCIENTIFIC REPORTS (2019)
Efficacy, Safety, and Durability of Voretigene Neparvovec-rzyl in RPE65 Mutation-Associated Inherited Retinal Dystrophy Results of Phase 1 and 3 Trials
Albert M. Maguire et al.
OPHTHALMOLOGY (2019)
Search-and-replace genome editing without double-strand breaks or donor DNA
Andrew V. Anzalone et al.
NATURE (2019)
Progress in Gene Therapy for Rhodopsin Autosomal Dominant Retinitis Pigmentosa
Raghavi Sudharsan et al.
RETINAL DEGENERATIVE DISEASES: MECHANISMS AND EXPERIMENTAL THERAPY (2019)
Cas9/sgRNA selective targeting of the P23H Rhodopsin mutant allele for treating retinitis pigmentosa by intravitreal AAV9.PHP.B-based delivery
Serena G. Giannelli et al.
HUMAN MOLECULAR GENETICS (2018)
Therapeutic applications of CRISPR/Cas9 system in gene therapy
Hasan Mollanoori et al.
BIOTECHNOLOGY LETTERS (2018)
Clustered Regularly Interspaced Short Palindromic Repeats-Based Genome Surgery for the Treatment of Autosomal Dominant Retinitis Pigmentosa
Yi-Ting Tsai et al.
OPHTHALMOLOGY (2018)
The molecular and cellular basis of rhodopsin retinitis pigmentosa reveals potential strategies for therapy
Dimitra Athanasiou et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2018)
Mutation-independent rhodopsin gene therapy by knockdown and replacement with a single AAV vector
Artur V. Cideciyan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Treatment of a metabolic liver disease by in vivo genome base editing in adult mice
Lukas Villiger et al.
NATURE MEDICINE (2018)
Base editing: precision chemistry on the genome and transcriptome of living cells
Holly A. Rees et al.
NATURE REVIEWS GENETICS (2018)
Allele-Specific CRISPR-Cas9 Genome Editing of the Single-Base P23H Mutation for Rhodopsin-Associated Dominant Retinitis Pigmentosa
Pingjuan Li et al.
CRISPR JOURNAL (2018)
Cas-analyzer: an online tool for assessing genome editing results using NGS data
Jeongbin Park et al.
BIOINFORMATICS (2017)
Correction of a pathogenic gene mutation in human embryos
Hong Ma et al.
NATURE (2017)
Evaluation of RNAi and CRISPR technologies by large-scale gene expression profiling in the Connectivity Map
Ian Smith et al.
PLOS BIOLOGY (2017)
Long-term retinal cone rescue using a capsid mutant AAV8 vector in a mouse model of CNGA3-achromatopsia
Xufeng Dai et al.
PLOS ONE (2017)
Targeting and silencing of rhodopsin by ectopic expression of the transcription factor KLF15
Salvatore Botta et al.
JCI INSIGHT (2017)
Cell cycle-dependent control of homologous recombination
Xin Zhao et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2017)
Applications of CRISPR-Cas systems in neuroscience
Matthias Heidenreich et al.
NATURE REVIEWS NEUROSCIENCE (2016)
Men and mice: Relating their ages
Sulagna Dutta et al.
LIFE SCIENCES (2016)
In Vivo CRISPR/Cas9 Gene Editing Corrects Retinal Dystrophy in the S334ter-3 Rat Model of Autosomal Dominant Retinitis Pigmentosa
Benjamin Bakondi et al.
MOLECULAR THERAPY (2016)
CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells
Daniel P. Dever et al.
NATURE (2016)
Rhodopsin targeted transcriptional silencing by DNA-binding
Salvatore Botta et al.
eLife (2016)
In vivo Editing of the Human Mutant Rhodopsin Gene by Electroporation of Plasmid-based CRISPR/Cas9 in the Mouse Retina
Maria Carmela Latella et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2016)
Therapeutic genome editing: prospects and challenges
David Benjamin Turitz Cox et al.
NATURE MEDICINE (2015)
Long-Term Effects of Retinal Gene Therapy in Childhood Blindness
Alan F. Wright
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Improvement and Decline in Vision with Gene Therapy in Childhood Blindness
Samuel G. Jacobson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Dual gRNAs guided CRISPR/Cas9 system inhibits hepatitis B virus replication
Jie Wang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Viral-mediated RdCVF and RdCVFL expression protects cone and rod photoreceptors in retinal degeneration
Leah C. Byrne et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Allele-Specific Inhibition of Rhodopsin With an Antisense Oligonucleotide Slows Photoreceptor Cell Degeneration
Susan F. Murray et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2015)
Efficient Ablation of Genes in Human Hematopoietic Stem and Effector Cells using CRISPR/Cas9
Pankaj K. Mandal et al.
CELL STEM CELL (2014)
Mutation-independent rescue of a novel mouse model of Retinitis Pigmentosa
D. L. Greenwald et al.
GENE THERAPY (2013)
Human retinal gene therapy for Leber congenital amaurosis shows advancing retinal degeneration despite enduring visual improvement
Artur V. Cideciyan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Gene-based therapies for dominantly inherited retinopathies
G. J. Farrar et al.
GENE THERAPY (2012)
Long-Term Rescue of Retinal Structure and Function by Rhodopsin RNA Replacement with a Single Adeno-Associated Viral Vector in P23H RHO Transgenic Mice
Haoyu Mao et al.
HUMAN GENE THERAPY (2012)
Mice with a D190N Mutation in the Gene Encoding Rhodopsin: A Model for Human Autosomal-Dominant Retinitis Pigmentosa
Javier Sancho-Pelluz et al.
MOLECULAR MEDICINE (2012)
Zinc-finger-based transcriptional repression of rhodopsin in a model of dominant retinitis pigmentosa
Claudio Mussolino et al.
EMBO MOLECULAR MEDICINE (2011)
Suppression and Replacement Gene Therapy for Autosomal Dominant Disease in a Murine Model of Dominant Retinitis Pigmentosa
Sophia Millington-Ward et al.
MOLECULAR THERAPY (2011)
Long-term Retinal Function and Structure Rescue Using Capsid Mutant AAV8 Vector in the rd10 Mouse, a Model of Recessive Retinitis Pigmentosa
Ji-jing Pang et al.
MOLECULAR THERAPY (2011)
Adenovirus-Associated Virus Vector-Mediated Gene Transfer in Hemophilia B
Amit C. Nathwani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Mislocalization and Degradation of Human P23H-Rhodopsin-GFP in a Knockin Mouse Model of Retinitis Pigmentosa
Brandee A. Price et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2011)
Improved Retinal Function in a Mouse Model of Dominant Retinitis Pigmentosa Following AAV-delivered Gene Therapy
Naomi Chadderton et al.
MOLECULAR THERAPY (2009)
High-efficiency Transduction of the Mouse Retina by Tyrosine-mutant AAV Serotype Vectors
Hilda Petrs-Silva et al.
MOLECULAR THERAPY (2009)
Transfection of small RNAs globally perturbs gene regulation by endogenous microRNAs
Aly A. Khan et al.
NATURE BIOTECHNOLOGY (2009)
Rhodopsin: The Functional Significance of Asn-Linked Glycosylation and Other Post-Translational Modifications
Anne R. Murray et al.
OPHTHALMIC GENETICS (2009)
Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics
Artur V. Cideciyan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Off-target effects by siRNA can induce toxic phenotype
Yuriy Fedorov et al.
RNA (2006)
Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways
Dirk Grimm et al.
NATURE (2006)
Gene therapy for autosomal dominant disorders of keratin
AS Lewin et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS (2005)
Knock-in human rhodopsin-GFP fusions as mouse models for human disease and targets for gene therapy
F Chan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Expression profiling reveals off-target gene regulation by RNAi
AL Jackson et al.
NATURE BIOTECHNOLOGY (2003)
Share Paper
